Lyell Immunopharma Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Lyell Immunopharma Inc   (NASDAQ: LYEL)

LYEL's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Y / Y Equity Change -35.17 % -41.55 % -21.4 % -10.38 % -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Lyell Immunopharma Inc 's Equity $ 248 Millions Annual LYEL's Balance sheet
Lyell Immunopharma Inc 's Annual Income $ -274 Millions Annual LYEL's Income Statement
Where are LYEL's Income coming from? Visit LYEL's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.